Tranexamic acid references

  1. Howard P, Curtin J (2020) Bleeding management in palliative medicine: subcutaneous tranexamic acid – retrospective chart review. Available at: Bleeding management in palliative medicine: subcutaneous tranexamic acid – retrospective chart review | BMJ Supportive & Palliative Care 
  2. Sood, R., Mancinetti, M., Betticher, D., Cantin, B., Ebneter, A. (2020) ‘Management of bleeding in palliative care patients in the general internal medicine ward: a systematic review’. Ann Med Surg (Lond). doi: 10.1016/j.amsu.2019.12.002. PMID: 31908774; PMCID: PMC6940657. 
  3. British National Formulary (2023) Tranexamic acid | Drugs | BNF | NICE
  4. Wilcock, A., Howard, P., Charlesworth, S (2022) Palliative care Formulary. Pharmaceutical press: London
  5. Hogg, R., Hedges, V., Bond, C (2022) ‘Case report: subcutaneous tranexamic acid administration via a continuous infusion successfully controlled bleeding at end of life’ BMJ Supportive & Palliative Care 2022;12:A36. P-73 Case report: subcutaneous tranexamic acid administration via a continuous infusion successfully controlled bleeding at end of life | BMJ Supportive & Palliative Care
  6. Medusa (2023) NHS injectable medicines guide. Available at: Injectable Medicines Guide – Display – Tranexamic acid – New version – Intravenous – Version 9 – IVGuideDisplayMain.asp (medusaimg.nhs.uk) [Accessed on: 21.01.24]

Disclaimer

These Guidelines are intended for use by healthcare professionals and the expectation is that they will use clinical judgement, medical, and nursing knowledge in applying the general principles and recommendations contained within. They are not meant to replace the many available texts on the subject of palliative care.

Some of the management strategies describe the use of drugs outside their licensed indications. They are, however, established and accepted good practice. Please refer to the current BNF for further guidance.

Whilst SPAGG takes every care to compile accurate information , we cannot guarantee its correctness and completeness, and it is subject to change. We do not accept responsibility for any loss, damage or expense resulting from the use of this information.